Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Neoplasm Metastasis Early Phase 1 ClinicalTrials
Breast Neoplasms Phase 2/Phase 3 ClinicalTrials
CONTENTS